Literature DB >> 2666143

Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.

R Gerardy-Schahn1, D Ambrosius, D Saunders, M Casaretto, C Mittler, G Karwarth, S Görgen, D Bitter-Suermann.   

Abstract

The expression of specific membrane receptors for C3a was determined on guinea pig C3a-sensitive (gp R+) platelets and human polymorphonuclear leukocytes (hu PMNL). Binding studies with 125I-labeled C3a from gp or hu sources and Scatchard analysis applied to the binding data revealed the existence of two receptor classes on gp R+ platelets; a high-affinity class with about 200 binding sites/cell and Kd = 1.7 x 10(-9) M, and a relatively low-affinity class with Kd = 10(-8) M and about 500 sites/cell. Hu PMNL express a homogeneous receptor class with Kd = 3 x 10(-8) M and 40,000 sites/cell. Molecular characterization of the C3a receptor on gp R+ platelets was achieved by (a) cross-linking photoaffinity-labeled receptors to bound 125I-labeled C3a; (b) photoaffinity labeling receptors with a 13-amino acid residue C3a analogue 125I-Nap-Ahx-13; and (c) use of chemical cross-linkers like disuccinimidylsuberate to cross-link receptors with 125I-C3a. All three techniques gave rise to very similar labeling patterns. With the photoaffinity labeling methods, a diffuse band pattern was observed with an apparent molecular mass of 95-123 kDa with 125I-C3a as label, and 85-105 kDa with 125I-Nap-Ahx-13 as label. Chemical cross-linking of 125I-C3a revealed three distinct bands with molecular masses of approximately 123, 108 and 95 kDa. Subtracting the contribution of the cross-linked ligands, the C3a receptor on gp R+ platelets appears to be a protein complex, consisting of one to three components with estimated molecular masses between 83-114 kDa.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666143     DOI: 10.1002/eji.1830190620

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.

Authors:  A Kola; A Klos; W Bautsch; T Kretzschmar; J Köhl
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Mechanisms of C5a and C3a complement fragment-induced [Ca2+]i signaling in mouse microglia.

Authors:  T Möller; C Nolte; R Burger; A Verkhratsky; H Kettenmann
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 3.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

4.  Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.

Authors:  J Zwirner; O Götze; G Begemann; A Kapp; K Kirchhoff; T Werfel
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

5.  Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.

Authors:  I Murray; J Köhl; K Cianflone
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

6.  Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping.

Authors:  D Suckau; J Köhl; G Karwath; K Schneider; M Casaretto; D Bitter-Suermann; M Przybylski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages.

Authors:  Y Murakami; T Imamichi; S Nagasawa
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

8.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.

Authors:  P J Daffern; P H Pfeifer; J A Ember; T E Hugli
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

9.  Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.

Authors:  M Oppermann; O Götze
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

10.  A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.

Authors:  W Bautsch; T Kretzschmar; T Stühmer; A Kola; M Emde; J Köhl; A Klos; D Bitter-Suermann
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.